MORI, MATTIA
MORI, MATTIA
Dipartimento di Biotecnologie, Chimica e Farmacia
(Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity
2020-01-01 Humbert, N; Kovalenko, L; Saladini, F; Giannini, A; Pires, M; Botzanowski, T; Cherenok, S; Boudier, C; Sharma, Kk; Real, E; Zaporozhets, Oa; Cianférani, S; Seguin-Devaux, C; Poggialini, F; Botta, M; Zazzi, M; Kalchenko, Vi; Mori, M; Mély, Y.
14-3-3 binding creates a memory of kinase action by stabilizing the modified state of phospholamban
2020-01-01 Menzel, J.; Kownatzki-Danger, D.; Tokar, S.; Ballone, A.; Unthan-Fechner, K.; Kilisch, M.; Lenz, C.; Urlaub, H.; Mori, M.; Ottmann, C.; Shattock, M. J.; Lehnart, S. E.; Schwappach, B.
1H-NMR metabolomics reveals the Glabrescione B exacerbation of glycolytic metabolism beside the cell growth inhibitory effect in glioma
2019-01-01 D'Alessandro, G.; Quaglio, D.; Monaco, L.; Lauro, C.; Ghirga, F.; Ingallina, C.; De Martino, M.; Fucile, S.; Porzia, A.; Di Castro, M. A.; Bellato, F.; Mastrotto, F.; Mori, M.; Infante, P.; Turano, P.; Salmaso, S.; Caliceti, P.; Di Marcotullio, L.; Botta, B.; Ghini, V.; Limatola, C.
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors
2010-01-01 Dreassi, Elena; Zizzari, ALESSANDRA TANIA; Mori, Mattia; Filippi, Irene; Belfiore, Amalia; Naldini, Antonella; Carraro, Fabio; Santucci, Annalisa; Schenone, Silvia; Botta, Maurizio
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein
2020-01-01 Malancona, Savina; Mori, Mattia; Fezzardi, Paola; Santoriello, Marisabella; Basta, Andreina; Nibbio, Martina; Kovalenko, Lesia; Speziale, Roberto; Battista, Maria Rosaria; Cellucci, Antonella; Gennari, Nadia; Monteagudo, Edith; Di Marco, Annalise; Giannini, Alessia; Sharma, Rajhans; Pires, Manuel; Real, Eleonore; Zazzi, Maurizio; Dasso Lang, Maria Chiara; De Forni, Davide; Saladini, Francesco; Mely, Yves; Summa, Vincenzo; Harper, Steven; Botta, Maurizio
A chalcone derivative binds a putative allosteric site of YopH: Inhibition of a virulence factor of Yersinia
2020-01-01 de Souza, A. C. A.; Mori, M.; Sens, L.; Rocha, R. F.; Tizziani, T.; de Souza, L. F. S.; Domeneghini Chiaradia-Delatorre, L.; Botta, M.; Nunes, R. J.; Terenzi, H.; Menegatti, A. C. O.
A Class of Potent Inhibitors of the HIV-1 Nucleocapsid Protein Based on Aminopyrrolic Scaffolds
2020-01-01 Ciaco, S.; Humbert, N.; Real, E.; Boudier, C.; Francesconi, O.; Roelens, S.; Nativi, C.; Seguin-Devaux, C.; Mori, M.; Mely, Y.
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors
2013-01-01 Mori, Mattia; Tintori, Cristina; Christopher, R. S. A.; Radi, M.; Schenone, S.; Musumeci, F.; Brullo, C.; Sanità, P.; Delle Monache, S.; Angelucci, A.; Kissova, M.; Crespan, E.; Maga, G.; Botta, M.
A deadly spillover: SARS-CoV-2 outbreak
2020-01-01 Mori, M.; Capasso, C.; Carta, F.; Donald, W. A.; Supuran, C. T.
A Highly Soluble Matrix Metalloproteinase-9 Inhibitor for Potential Treatment of Dry Eye Syndrome
2012-01-01 Mori, Mattia; Emanuele De, Lorenzo; Torre, Eugenio; Fragai, Marco; Nativi, Cristina; Luchinat, Claudio; Arcangeli, Annarosa
A Molecular Tool Targeting the Base-Flipping Activity of Human UHRF1
2019-01-01 Zaayter, L.; Mori, M.; Ahmad, T.; Ashraf, W.; Boudier, C.; Kilin, V.; Gavvala, K.; Richert, L.; Eiler, S.; Ruff, M.; Botta, M.; Bronner, C.; Mousli, M.; Mely, Y.
A novel colistin adjuvant identified by virtual screening for ArnT inhibitors
2020-01-01 Ghirga, F.; Stefanelli, R.; Cavinato, L.; Lo Sciuto, A.; Corradi, S.; Quaglio, D.; Calcaterra, A.; Casciaro, B.; Loffredo, M. R.; Cappiello, F.; Morelli, P.; Antonelli, A.; Rossolini, G. M.; Mangoni, M.; Mancone, C.; Botta, B.; Mori, M.; Ascenzioni, F.; Imperi, F.
A selective competitive inhibitor of aldehyde dehydrogenase 1A3 hinders cancer cell growth, invasiveness and stemness in vitro
2021-01-01 Gelardi, E. L. M.; Colombo, G.; Picarazzi, F.; Ferraris, D. M.; Mangione, A.; Petrarolo, G.; Aronica, E.; Rizzi, M.; Mori, M.; La Motta, C.; Garavaglia, S.
A smo/gli multitarget hedgehog pathway inhibitor impairs tumor growth
2019-01-01 Severini, L. L.; Quaglio, D.; Basili, I.; Ghirga, F.; Bufalieri, F.; Caimano, M.; Balducci, S.; Moretti, M.; Romeo, I.; Loricchio, E.; Maroder, M.; Botta, B.; Mori, M.; Infante, P.; Di Marcotullio, L.
Acipimox inhibits human carbonic anhydrases
2022-01-01 Mori, M.; Supuran, C. T.
Active Components from Cassia abbreviata Prevent HIV-1 Entry by Distinct Mechanisms of Action
2021-01-01 Zheng, Yue; Yang, Xian-Wen; Schols, Dominique; Mori, Mattia; Botta, Bruno; Chevigné, Andy; Mulinge, Martin; Steinmetz, André; Schmit, Jean-Claude; Seguin-Devaux, Carole
Alvaxanthone, a thymidylate synthase inhibitor with nematocidal and tumoricidal activities
2020-01-01 Maj, P.; Mori, M.; Sobich, J.; Markowicz, J.; Uram, L.; Zielinski, Z.; Quaglio, D.; Calcaterra, A.; Cau, Y.; Botta, B.; Rode, W.
Antimalarial drugs: what's new in the patents?
2023-01-01 Lopes, Elizabeth A; Santos, Maria M M; Mori, Mattia
Chalcones and Chalcone-mimetic Derivatives as Notch Inhibitors in a Model of T-cell Acute Lymphoblastic Leukemia
2019-01-01 Quaglio, D.; Zhdanovskaya, N.; Tobajas, G.; Cuartas, V.; Balducci, S.; Christodoulou, M. S.; Fabrizi, G.; Gargantilla, M.; Priego, E. -M.; Carmona Pestania, A.; Passarella, D.; Screpanti, I.; Botta, B.; Palermo, R.; Mori, M.; Ghirga, F.; Perez-Perez, M. -J.
Chemical, computational and functional insights into the chemical stability of the Hedgehog pathway inhibitor GANT61
2018-01-01 Calcaterra, A.; Iovine, V.; Botta, B.; Quaglio, D.; D'Acquarica, I.; Ciogli, A.; Iazzetti, A.; Alfonsi, R.; Lospinoso Severini, L.; Infante, P.; Di Marcotullio, L.; Mori, M.; Ghirga, F.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| (Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity | 1-gen-2020 | Humbert, N; Kovalenko, L; Saladini, F; Giannini, A; Pires, M; Botzanowski, T; Cherenok, S; Boudier, C; Sharma, Kk; Real, E; Zaporozhets, Oa; Cianférani, S; Seguin-Devaux, C; Poggialini, F; Botta, M; Zazzi, M; Kalchenko, Vi; Mori, M; Mély, Y. | - | |
| 14-3-3 binding creates a memory of kinase action by stabilizing the modified state of phospholamban | 1-gen-2020 | Menzel, J.; Kownatzki-Danger, D.; Tokar, S.; Ballone, A.; Unthan-Fechner, K.; Kilisch, M.; Lenz, C.; Urlaub, H.; Mori, M.; Ottmann, C.; Shattock, M. J.; Lehnart, S. E.; Schwappach, B. | - | |
| 1H-NMR metabolomics reveals the Glabrescione B exacerbation of glycolytic metabolism beside the cell growth inhibitory effect in glioma | 1-gen-2019 | D'Alessandro, G.; Quaglio, D.; Monaco, L.; Lauro, C.; Ghirga, F.; Ingallina, C.; De Martino, M.; Fucile, S.; Porzia, A.; Di Castro, M. A.; Bellato, F.; Mastrotto, F.; Mori, M.; Infante, P.; Turano, P.; Salmaso, S.; Caliceti, P.; Di Marcotullio, L.; Botta, B.; Ghini, V.; Limatola, C. | - | |
| 2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors | 1-gen-2010 | Dreassi, Elena; Zizzari, ALESSANDRA TANIA; Mori, Mattia; Filippi, Irene; Belfiore, Amalia; Naldini, Antonella; Carraro, Fabio; Santucci, Annalisa; Schenone, Silvia; Botta, Maurizio | - | |
| 5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein | 1-gen-2020 | Malancona, Savina; Mori, Mattia; Fezzardi, Paola; Santoriello, Marisabella; Basta, Andreina; Nibbio, Martina; Kovalenko, Lesia; Speziale, Roberto; Battista, Maria Rosaria; Cellucci, Antonella; Gennari, Nadia; Monteagudo, Edith; Di Marco, Annalise; Giannini, Alessia; Sharma, Rajhans; Pires, Manuel; Real, Eleonore; Zazzi, Maurizio; Dasso Lang, Maria Chiara; De Forni, Davide; Saladini, Francesco; Mely, Yves; Summa, Vincenzo; Harper, Steven; Botta, Maurizio | - | |
| A chalcone derivative binds a putative allosteric site of YopH: Inhibition of a virulence factor of Yersinia | 1-gen-2020 | de Souza, A. C. A.; Mori, M.; Sens, L.; Rocha, R. F.; Tizziani, T.; de Souza, L. F. S.; Domeneghini Chiaradia-Delatorre, L.; Botta, M.; Nunes, R. J.; Terenzi, H.; Menegatti, A. C. O. | - | |
| A Class of Potent Inhibitors of the HIV-1 Nucleocapsid Protein Based on Aminopyrrolic Scaffolds | 1-gen-2020 | Ciaco, S.; Humbert, N.; Real, E.; Boudier, C.; Francesconi, O.; Roelens, S.; Nativi, C.; Seguin-Devaux, C.; Mori, M.; Mely, Y. | - | |
| A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors | 1-gen-2013 | Mori, Mattia; Tintori, Cristina; Christopher, R. S. A.; Radi, M.; Schenone, S.; Musumeci, F.; Brullo, C.; Sanità, P.; Delle Monache, S.; Angelucci, A.; Kissova, M.; Crespan, E.; Maga, G.; Botta, M. | - | |
| A deadly spillover: SARS-CoV-2 outbreak | 1-gen-2020 | Mori, M.; Capasso, C.; Carta, F.; Donald, W. A.; Supuran, C. T. | - | |
| A Highly Soluble Matrix Metalloproteinase-9 Inhibitor for Potential Treatment of Dry Eye Syndrome | 1-gen-2012 | Mori, Mattia; Emanuele De, Lorenzo; Torre, Eugenio; Fragai, Marco; Nativi, Cristina; Luchinat, Claudio; Arcangeli, Annarosa | - | |
| A Molecular Tool Targeting the Base-Flipping Activity of Human UHRF1 | 1-gen-2019 | Zaayter, L.; Mori, M.; Ahmad, T.; Ashraf, W.; Boudier, C.; Kilin, V.; Gavvala, K.; Richert, L.; Eiler, S.; Ruff, M.; Botta, M.; Bronner, C.; Mousli, M.; Mely, Y. | - | |
| A novel colistin adjuvant identified by virtual screening for ArnT inhibitors | 1-gen-2020 | Ghirga, F.; Stefanelli, R.; Cavinato, L.; Lo Sciuto, A.; Corradi, S.; Quaglio, D.; Calcaterra, A.; Casciaro, B.; Loffredo, M. R.; Cappiello, F.; Morelli, P.; Antonelli, A.; Rossolini, G. M.; Mangoni, M.; Mancone, C.; Botta, B.; Mori, M.; Ascenzioni, F.; Imperi, F. | - | |
| A selective competitive inhibitor of aldehyde dehydrogenase 1A3 hinders cancer cell growth, invasiveness and stemness in vitro | 1-gen-2021 | Gelardi, E. L. M.; Colombo, G.; Picarazzi, F.; Ferraris, D. M.; Mangione, A.; Petrarolo, G.; Aronica, E.; Rizzi, M.; Mori, M.; La Motta, C.; Garavaglia, S. | - | |
| A smo/gli multitarget hedgehog pathway inhibitor impairs tumor growth | 1-gen-2019 | Severini, L. L.; Quaglio, D.; Basili, I.; Ghirga, F.; Bufalieri, F.; Caimano, M.; Balducci, S.; Moretti, M.; Romeo, I.; Loricchio, E.; Maroder, M.; Botta, B.; Mori, M.; Infante, P.; Di Marcotullio, L. | - | |
| Acipimox inhibits human carbonic anhydrases | 1-gen-2022 | Mori, M.; Supuran, C. T. | - | |
| Active Components from Cassia abbreviata Prevent HIV-1 Entry by Distinct Mechanisms of Action | 1-gen-2021 | Zheng, Yue; Yang, Xian-Wen; Schols, Dominique; Mori, Mattia; Botta, Bruno; Chevigné, Andy; Mulinge, Martin; Steinmetz, André; Schmit, Jean-Claude; Seguin-Devaux, Carole | - | |
| Alvaxanthone, a thymidylate synthase inhibitor with nematocidal and tumoricidal activities | 1-gen-2020 | Maj, P.; Mori, M.; Sobich, J.; Markowicz, J.; Uram, L.; Zielinski, Z.; Quaglio, D.; Calcaterra, A.; Cau, Y.; Botta, B.; Rode, W. | - | |
| Antimalarial drugs: what's new in the patents? | 1-gen-2023 | Lopes, Elizabeth A; Santos, Maria M M; Mori, Mattia | - | |
| Chalcones and Chalcone-mimetic Derivatives as Notch Inhibitors in a Model of T-cell Acute Lymphoblastic Leukemia | 1-gen-2019 | Quaglio, D.; Zhdanovskaya, N.; Tobajas, G.; Cuartas, V.; Balducci, S.; Christodoulou, M. S.; Fabrizi, G.; Gargantilla, M.; Priego, E. -M.; Carmona Pestania, A.; Passarella, D.; Screpanti, I.; Botta, B.; Palermo, R.; Mori, M.; Ghirga, F.; Perez-Perez, M. -J. | - | |
| Chemical, computational and functional insights into the chemical stability of the Hedgehog pathway inhibitor GANT61 | 1-gen-2018 | Calcaterra, A.; Iovine, V.; Botta, B.; Quaglio, D.; D'Acquarica, I.; Ciogli, A.; Iazzetti, A.; Alfonsi, R.; Lospinoso Severini, L.; Infante, P.; Di Marcotullio, L.; Mori, M.; Ghirga, F. | - |